Dooner, M.S., Aliotta, J.M., Pimental, J., Dooner, G.J., Abedi, M., Colvin, G., Liu, Q., Weier, H-U., Johnson, K
In vivo photoreceptor degeneration assessment in rd10 and rd10/Serpinf1 -/- murine models -/- Fluorescence fundoscopy with a cell death probe was chosen as a simple method for monitoring photoreceptor cell death in alive animals 36
Cushing's syndrome, though rare, causes weight gain through cortisol excess that weight loss injections cannot adequately address
These predispositions do not predict exact medication response or determine candidacy alonemedical history, contraindications, and current health status remain the primary determinants of safety and eligibility
Before starting GLP-1 therapy , discuss existing cognitive symptoms with your physician
While there is currently a registered study to examine the effect of sulforaphane in patient populations with attention-deficit disorder with or without hyperactivity in children 612 years old (NCT06594536), as well as a study currently recruiting to evaluate the effects of sulforaphane in PD patients (NCT05084365), and a clinical study registered to examine AD (NCT04213391), there remains large gaps in the literature regarding the efficacy of sulforaphane as a treatment for neurological disorders
